phosphorylcholine has been researched along with betadex in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Herrmann, A; John, K; Kubelt, J; Müller, P; Wüstner, D | 1 |
| Fujii, M; Ishihara, H; Kagawa, Y; Koizumi, H; Nomura, S; Oka, F; Owada, Y; Sadahiro, H; Shinoyama, M; Shirao, S; Sugimoto, K; Suzuki, M; Tamechika, M; Yoneda, H | 1 |
| Chang, F; Li, WJ; Liu, J; Liu, PP; Miao, JY; Yue, HW; Zhao, J | 1 |
| Carballo, D; McInally, K; Normand, P; Piché, C; Reno, FE; Silo, S; Stotland, P; Triest, M | 1 |
| Ceriani, V; Pontiroli, AE | 1 |
| Chen, X; Feng, Y; Gao, S; Li, J; Wang, Z; Xin, Q; Zhang, W | 1 |
1 review(s) available for phosphorylcholine and betadex
| Article | Year |
|---|---|
Intranasal glucagon for hypoglycaemia in diabetic patients. An old dream is becoming reality?
Topics: Adjuvants, Pharmaceutic; Administration, Intranasal; beta-Cyclodextrins; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Drug Compounding; Emergency Treatment; Glucagon; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Phosphorylcholine; Powders; Severity of Illness Index | 2018 |
5 other study(ies) available for phosphorylcholine and betadex
| Article | Year |
|---|---|
Rapid transbilayer movement of the fluorescent sterol dehydroergosterol in lipid membranes.
Topics: beta-Cyclodextrins; Biophysical Phenomena; Biophysics; Cyclodextrins; Ergosterol; Fluorescence Resonance Energy Transfer; Kinetics; Lipid Bilayers; Lipids; Liposomes; Models, Theoretical; Phosphorylcholine; Spectrometry, Fluorescence; Spectrophotometry; Sterols; Temperature | 2002 |
A novel trigger for cholesterol-dependent smooth muscle contraction mediated by the sphingosylphosphorylcholine-Rho-kinase pathway in the rat basilar artery: a mechanistic role for lipid rafts.
Topics: Amides; Animals; Antihypertensive Agents; Basilar Artery; beta-Cyclodextrins; Carotid Artery, Internal; Cholesterol; Dietary Fats; Male; Membrane Microdomains; Membrane Proteins; Muscle Contraction; Muscle, Smooth, Vascular; Phosphorylcholine; Pyridines; Rats; Rats, Sprague-Dawley; rho-Associated Kinases; Signal Transduction; Sphingosine; Vasospasm, Intracranial | 2015 |
Sphingosylphosphorylcholine protects cardiomyocytes against ischemic apoptosis via lipid raft/PTEN/Akt1/mTOR mediated autophagy.
Topics: Adenine; Animals; Animals, Newborn; Apoptosis; Autophagy; beta-Cyclodextrins; Carrier Proteins; Gene Expression Regulation; Intracellular Signaling Peptides and Proteins; MAP Kinase Kinase 4; Membrane Microdomains; Microtubule-Associated Proteins; Mitogen-Activated Protein Kinase 8; Myocytes, Cardiac; Phosphoproteins; Phosphorylcholine; Primary Cell Culture; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Rats; Rats, Sprague-Dawley; Recombinant Fusion Proteins; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; Sphingosine; TOR Serine-Threonine Kinases | 2015 |
A novel nasal powder formulation of glucagon: toxicology studies in animal models.
Topics: Administration, Intranasal; Animals; Area Under Curve; beta-Cyclodextrins; Body Weight; Dogs; Female; Glucagon; Humans; Lung; Male; Metabolic Clearance Rate; Models, Animal; Organ Size; Phosphorylcholine; Powders; Rabbits; Rats, Sprague-Dawley; Species Specificity; Survival Analysis; Time Factors; Toxicity Tests | 2015 |
Cell-Membrane-Targeted Drug Delivery System Based on Choline-Phosphate-Functionalized β-Cyclodextrin.
Topics: beta-Cyclodextrins; Cell Membrane; Drug Carriers; Drug Delivery Systems; Humans; Phosphorylcholine; Solubility; Water | 2020 |